UK Biobank gets national go-ahead:
This article was originally published in Clinica
Executive Summary
The UK Biobank project has been given the go-ahead to go national, following the success of its three-month, 3,800-subject pilot phase. Over the next 10 years, up to half a million people aged 40-69 will be invited to provide genetic and medical data and samples, with the aim of building a database, the analysis of which will be used to inform preventive, diagnostic and therapeutic policies. It also promises to support groundbreaking research into lifestyle and environmental influence on health. The pilot of the £61m ($115m) project is also noted for having set, it is claimed, new standards in automated blood-sample processing and tracking.
You may also be interested in...
EU Regulatory Assessors Get AI Boost In Reaching Scientific Decisions
The European Medicines Agency is training scientific staff working for the European medicines regulatory network in how to use a new AI-powered search engine that allows them to easily retrieve information on regulatory precedents.
EU Parliament Stricter Than Council On Medicines And Medical Devices Packaging
The EU Parliament's Environment, Public Health and Food Safety committee takes a compromise position with regards to the Packaging and Packaging Waste Directive. Medicines and medical devices should be exempt, but only until 2035, at which point the European Commission should check whether the development of materials and the recycling process have progressed, and may adjust this exemption accordingly.
Stay Or Exit? Global Health Players Ponder New China Trajectory
It's again the time of year when global CEOs descend on China's capital to discuss strategies. This year, however, the mood is different.